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1. Introduction 
During protein synthesis peptidyl-tRNA is trans- 
located from the ribosomal A site to the P site in a 
reaction requiring the protein elongation factor G 
(EF-G) and hydrolysis of one molecule of GTP [ 1, 
21. Although fusidic acid was originally found to in- 
hibit both GTP hydrolysis [3] and translocation-de- 
pendent reactions in vitro [3-51 it was later demon- 
strated that one round of GTP hydrolysis could oc- 
cur in the presence of the drug [6]. The resultant 
ribosome-EF-G-GDP complexes [7] were, however, 
stabilized and it was suggested that fusidic acid in- 
hibits protein synthesis by preventing dissociation of 
these complexes, implying an inhibition of transloca- 
tion. However, there have recently been reports that 
fusidic acid blocked peptidyl-tRNA in the ribosomal 
P site, both in vivo [8] and in vitro [9] in contrast 
to the expected behaviour if translocation were in- 
hibited by the antibiotic. 
The aim of the present experiments was to recon- 
cile the apparent contradictions between the earlier 
evidence and the more recent work on the mode of 
action of fusidic acid. Our results show that while 
under certain conditions fusidic acid can slow down 
translocation in vitro (without completely inhibiting 
this process) this inhibitory effect is misleading since 
it is closely dependent on the concentration of EF-G 
used in the incubation mixture. Indeed, when a mo- 
lar excess of EF-G, relative to ribosomes, is employed 
fusidic acid neither inhibits the rate nor the extent 
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of translocation and instead blocks peptidyl-tRNA 
in the ribosomal P site as suggested recently [8, 91. 
2. Materials and methods 
Escherichia coli (strain B163) was grown to late 
logarithmic phase, rapidly chilled, harvested and the 
cells stored frozen until use [lo]. Crude extracts 
were prepared [ 1 l] and adjusted to a ribosome con- 
centration of 10 mg/ml. 14C-labelled amino acids 
were incorporated into peptidyl-tRNA as directed 
by the endogenous mRNA of the extract and as de- 
scribed previously [ 111. 
Ribosome-free supernatant fraction was obtained 
from crude extracts by centrifugation [ 1 l] and was 
dialysed for 18 hr at 4°C against 5 mM Tris-Cl buf- 
fer, pH 7.4, containing 10 mM magnesium acetate, 
86 mM potassium chloride and 6 mM 2-mercapto- 
ethanol. The supernatant fraction was stoed in small 
aliquots at -20°C and was used as an unpurified 
source of EF-G. 
2.1. Translocation studies 
For translocation studies incorporation mixtures 
were diluted with 5 mM Tris-Cl buffer, pH 7.4, con- 
taining 10 mM magnesium acetate, 0.5 M ammonium 
chloride and 15% (w/v) sucrose and ribosomes were 
pelletted by centrifugation at 165 000 g for 1 hr. 
Ribosome pellets were resuspended and the washing 
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procedure repeated three times to remove all traces 
of bound EF-G. Ribosomes were finally resuspended 
to a concentration of 3 mg/ml in 5 mM Tris-Cl 
buffer, pH 7.4, containing 10 mM magnesium acetate 
and 86 mM potassium chloride. Samples were in- 
cubated with puromycin (0.1 mM) and other com- 
ponents as described in the figure legends and release 
from ribosomes of 14C-labelled peptide estimated as 
previously described [ 11, 121. 
2.2. Studies on the distribution of peptidyl-tRNA be- 
tween ribosomul binding sites 
Ribosomes were isolated from crude extracts of 
E. coli actively synthesizing peptide. One incubation 
mixture was inhibited with 3 mM fusidic acid and a 
second sample inhibited with chlortetracycline (100 
,ug/ml). Ribosomes were prepared by dilution of in- 
cubation mixtures with 5 mM Tris-Cl buffer, pH 
7.4, containing 10 mM magnesium acetate and 86 
mM potassium chloride, followed by centrifugation 
as in 2.1 above. Release of peptide by puromycin 
was determined as described under section 2.1. 
Purified EF-G was a generous gift from Dr. J.W. 
Bodley. Sodium fusidate was obtained from Leo La- 
boratories Ltd. 14C-labelled Chlorella protein hydro- 
lysate (52 mCi/matom carbon) was obtained from 
the Radiochemical Centre (Amersham, England). 
Puromycin dihydrochloride was obtained from the 
Nutritional Biochemical Corporation, Cleveland, Ohio, 
USA. 
3. Results and discussion 
Release of nascent peptides from isolated, washed 
ribosomes by puromycin is used as an assay for the 
peptidyl transferase enzyme on the 50 S ribosomal 
sununit. In the absence of translocation, onlypeptidyl- 
tRNA bound to the ribosomal P site can react with 
puromycin. Release of peptide can be followed as a 
decrease in ribosome-associated 14C- counts. 
In control incubations from which supernatant 
fraction and GTP were omitted from ribosome sus- 
pensions approximately 35% of the total ribosome- 
bound radioactive peptide was released (from the 
ribosomal P site) over a 10 min incubation period 
(fig. 1). Where ribosomes were incubated with GTP 
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Fig. 1. Effect of fusidic acid on the puromycin reaction 
with washed ribosomes in the presence of GTP and either 
supernatant fraction or purified EF-G. Labelled ribosome 
suspensions (specific activity 20 000 dumimg) were pre- 
pared as described in section 2.1. Samplesin a final volume 
of 1 ml contained ribosomes (1.5 mg), ATP (1 Fmole), 
phosphoenolpyruvate (5 pmole), GTP (0.3 pmole), pyruvate 
kinase (50 pg), supernatant fraction and puromycin (0.1 
mM). For experiments using purified EF-G ATP, phospho- 
enolpyruvate and pyruvate kinase were omitted and GTP 
(0.15 pmole) added. Incubations at 30°C were in the pre- 
sence or absence of fuside acid (0.3 mM). Samples were 
chilled on ice, ribosomes isolated and release of nascent 
protein determined as described in section 2.1. (0) Control 
ribosomes incubated as above in the presence of either 
supernatant fraction (0.02 ml or 0.2 ml) OI purified EF-G 
(0.08 pmole or 0.8 pmole). (0) Fusidic acid present along 
with supernatant fraction (0.02 ml) or purified EF-G 
(0.08 pmole). (0) Fusidic acid present along with super- 
natant fraction (0.2 ml) or purified EF-G (0.8 pmole). (m) 
Control ribosomes incubated with puromycin alone. 
and either supernatant fraction or purified EF-G 
(fig. 1) those peptides (30-35% of the total) which 
were released promptly, even at O”C, were assumed 
to have been bound in the ribosomal P site as pep- 
tidyl-tRNA. A further 35% of Ihe radioactive pep- 
tides were released over a 5 min incubation in a reac- 
tion dependent upon translocation of peptidyl-tRNA 
from the ribosomal A site to the P site. Addition of 
0.3 mM fusidic acid causes a considerable slowing of 
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Fig. 2. Effect of fusidic acid on the puromycin reaction 
with washed ribosomes in the presence of GTP and differ- 
ent concentrations of supernatant fraction or purified EF-G. 
Conditions for this experiment are described in the legend 
to fig. 1 except that different amounts of either superna- 
tant fraction or EF-G were added as indicated. Incubation 
was at 30°C for 2.5 min; Release of nascent protein from 
ribosomes was determined as under fig. 1. Results with 
either supernatant fraction or purified EF-G were identical: 
(o) control; (0) fusidic acid present. 
this translocation-dependent release when limiting 
amounts of EF-G are used - conditions which ap- 
proximate those used previously by others (3-5). 
However, in E. coli extracts prepared as in the pre- 
sent work, only approximately 10% of the ribosomes 
are ‘active’ in protein synthesis [ 131. In the experi- 
ments presented in fig. 1 EF-G, whether added as 
purified factor or as crude supernatant fraction, was 
present either in a slight molar excess with respect 
to the ‘active’ ribosomes or in lo-fold greater con- 
centration, assuming the values for EF-G content of 
E. coli calculated by Gordon [14]. In all cases fusidic 
acid was present in considerable molar excess with 
respect to other components. As seen in fig. 1 
whether or not fusidic acid inhibited translocation 
was closely dependent upon the relative concentra- 
tions of EF-G and ribosomes. 
It has been suggested [8, 151 that sequestration 
Table 1 
Inhibition of ribosomes in the puromycin reaction by pre- 
treatment of crude extracts with either fusidic acid or 
chlortetracycline during protein synthesis 
____.---~ 
System Protein released from ribo- 
somes by puromycin (%) 
_____._______. 
(a) Control ribosomes 36 
(b) Ribosomes from extracts 
treated with fusidic acid 45 
(c) Ribosomes from extracts 
treated with chlortetracycline 54 
(d) Control ribosomes 
incubated with GTP 67 
Incorporation mixtures were incubated for 5 min at 30°C. 
Two control samples (1.5 ml each) were chilled on ice and 
to two other samples (1.5 ml) was added fusidic acid (3 
mM) or chlortetracycline (100 pg/ml). Incubation was con- 
tinued for 5 min before chilling. Ribosomes were isolated 
as described in Materials and methods and after resuspen- 
sion 1 ml samples (a), (b) and (c) were incubated with 
puromycin (0.1 mM) alone for 5 min. Sample (d) was in- 
cubated with puromycin (0.1 mM) in addition to a reac- 
tion mixture (1 ml) containing phosphoenolpyruvate (5 
pmole), ATP (1 pmole), GTP (0.15 Mmole), pyruvate 
kinase (50 pug), 2-mercaptoethanol (6 bmole) and superna- 
tant fraction (0.2 ml). The amount of peptide released 
from ribosomes by puromycin was determined as described 
under fig. 1. 
of EF-G on inactive ribosomes might account, at 
least in part, for the inhibition of translocation by 
fusidic acid as reported by others [3-51. Such seque-, 
stration would reduce the amount of EF-G available 
to ‘active’ ribosomes particularly if the levels of EF-G 
employed were limiting. The data in fig. 1 support 
such an interpretation as does the data of fig. 2 
where the effect of fusidic acid on one round of 
translocation was investigated in the presence of a 
range of EF-G concentrations. Increasing the con- 
centration of the factor overcomes the inhibition of 
translocation which can be caused by fusidic acid. 
This observation correlates well with the report by 
Kaji et al. [16] that EF-G dependent release of 
deacylated-tRNA from ribosomes - an event nor- 
mally associated with translocation - is insensitive 
to fusidic acid when an excess of EF-G is employed. 
Both their observations [16] and ours.are consistent 
with the sequestration theory as outlined above. In 
our experiments we note that in the absence of 
221 
Volume 40, number 1 FEBS LETTERS March 1974 
fusidic acid the system reaches saturation with EF-G 
when this factor and the ‘active’ ribosomes are pre- 
sent in approximately equimolar concentrations. The 
presence of 0.3 mM fusidic acid increases four or 
five-fold the concentration of EF-G necessary for 
maximal release of peptide. 
In our opinion these results reconcile apparent 
contradictions in the literature and establish the se- 
questration hypothesis [8, 151 as the underlying 
cause of this discrepancy. We stress that any inhibi- 
tory action of fusidic acid upon translocation, ex- 
pressed in vitro, is probably artificial since in intact 
bacteria elongation factors for protein synthesis are 
apparently not present in limiting quantity [14] and 
it is most improbable that growing cells normally 
contain a large proportion of inactive ribosomes. 
Finally, we studied the effect of fusidic acid in a 
complete protein synthesizing system - a crude ex- 
tract of E. coli supplemented with a mixture of 
14C-labelled amino acids together with an energy- 
generating source [ 121. This system utilises endo- 
genous mRNA. After treatment of such a system 
with fusidic acid, ribosomes were isolated and as- 
sayed for reactivity towards puromycin. The results 
are presented in table 1. Following incubation with 
fusidic acid the distribution of peptidyl-tRNA be- 
tween ribosomal sites is altered in such a way that 
the amount of material capable of reacting with 
puromycin, in the absence of added GTP and super- 
natant fraction is increased. For comparison, the 
effect of chlortetracycline in an identical system is 
also shown (table lc). Chlortetracycline prevents 
aminoacyl-tRNA binding at the ribosomal A site 
and peptidyl-tRNA is blocked in the ribosomal P 
site resulting in an increase in puromycin reactivity 
[ 121. The total amount of peptidyl-tRNA which is 
potentially capable of reacting with puromycin on 
ribosomes isolated from an uninhibited system is 
given in table 1 (d) where incubation of such ribo- 
somes with GTP and supernatant fraction allows 
translocation. In this case peptidyl-tRNA present in 
both ribosomal A and P sites at the time of removal 
from the complete system reacts subsequently with 
puromycin. The data in table 1 indicate that both 
fusidic acid and chlortetracycline produce similar 
results in the system with a more pronounced effect 
for the latter antibiotic. Furthermore, the results do 
not suggest that fusidic acid, employed as above in a 
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complete cell-free system, inhibits translocation in 
vitro since such an inhibition would block peptidyl- 
tRNA in the ribosomal A site [ 121 and would allow 
less reaction with puromycin, as previously observed 
with erythromycin [ 121. 
This result can be rationalized according to the 
single ‘GTPase’ model of ribosome function in which 
EF-G and elongation factor Tu (EF-Tu) interact 
alternately with a common ribosomal site (or in 
mutually exclusive fashion with two adjacent sites) 
in or near the A site moiety of the 50 S ribosomal 
subunit [ 17, IS]. A complex of EF-G and GDP on 
this ‘GTPase’ centre, stabilized by fusidic acid, would 
inhibit not translocation but rather the next essential 
function of that site which would be an interaction 
with an (aminoacyl-tRNA-EF-Tu-GTP) complex. 
Such an inhibitory effect would be expected to 
block peptidyl-tRNA in the ribosomal P site [8] 
since fusidic acid would primarily inhibit the binding 
of aminoacyl-tRNA into the ribosomal A site after 
a translocation event had occurred. 
Although our data are consistent with this inter- 
pretation, the blockage caused by fusidic acid is 
clearly not complete and our observation may be 
more in line with the long term effects obtained 
with this drug in vivo [ 191 . Thus, while fusidic acid 
initially confines peptidyl-tRNA to the ribosomal P 
site, a slow cycle is eventually established and pep- 
tidyl-tRNA enters and leaves both sites. According 
to this model fusidic acid can hold peptidyl-tRNA 
in either ribosomal site, although less efficiently in 
the A than in the P site - consistent with a second- 
ary effect of fusidic acid possibly on translocation 
itself. We do not know if this effect is related to the 
sequestration of EF-G discussed earlier although we 
note that the presence of EF-G and GDP on the 
‘GTPase’ site might inhibit translocation by excluding 
GTP. Such a situation might arise at unusually high 
GDP/GTP ratios. Alternative explanations might 
be connected with a recent report [20] that fusidic 
acid can affect both ribosomal A and P sites under 
particular conditions. 
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